This is the same recommendation the American Heart Association makes for cardiovascular health, but it has direct benefits for gut motility too
This article examines how GLP-1 medications influence bowel function and provides practical guidance for managing digestive symptoms
Heres what the evidence really shows
Healthcare providers may recommend laboratory testing to identify specific deficiencies before starting supplementation, particularly for patients with reduced food intake or persistent gastrointestinal symptoms
Interestingly, although vascular SCFAs activate EECs, vascular administration of a GPR43 agonist did not induce gut peptide secretion, and vascular coadministration of butyrate with a GPR41 antagonist did not impede gut peptide secretion 93
Of note, ex vivo isolated islet experiments do not simulate the full range of regulation present in vivo under T2DM conditions [207], which requires further investigation to clarify